Idexx Laboratories (IDXX) Gross Profit (2009 - 2026)

Idexx Laboratories has reported Gross Profit for 18 years, with the latest figure at $779.1 million in Q2 2026.

• On a quarterly basis, Gross Profit rose 12.14% year-over-year to $779.1 million in Q2 2026; TTM through Jun 2026 was $2.8 billion, a 14.43% increase from a year earlier, with the FY2025 full-year figure at $2.7 billion, up 11.8% from the prior year.
• Gross Profit was $779.1 million for Q2 2026 at Idexx Laboratories, up from $722.7 million in the prior quarter.
• The five-year high for Gross Profit was $779.1 million in Q2 2026, with the low at $484.9 million in Q4 2022.
• Average Gross Profit over 5 years is $596.4 million, with a median of $583.0 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Gross Profit climbed 5.05% in 2022, then grew 15.94% in 2026.
• Over 5 years, Gross Profit stood at $484.9 million in 2022, then advanced by 8.5% to $526.2 million in 2023, then grew by 8.46% to $570.7 million in 2024, then rose by 15.33% to $658.1 million in 2025, then advanced by 18.38% to $779.1 million in 2026.
• The last three Gross Profit figures came in at $779.1 million (Q2 2026), $722.7 million (Q1 2026), and $658.1 million (Q4 2025), per Business Quant data.